You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selectin Inhibitor

Showing 26 - 50 of 7,510
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hypertension, Aging, Sedentary Lifestyle Trial in Birmingham, Aurora, Orlando (Aerobic exercise, Perindopril, Losartan)

Recruiting
  • Hypertension
  • +2 more
  • Aerobic exercise
  • +3 more
  • Birmingham, Alabama
  • +2 more
May 6, 2022

Correcting Platelet Dysfunction After Traumatic Brain Injury

Completed
  • Platelet Dysfunction
  • Traumatic Brain Injury
  • Platelet mapping Thromboelastography
  • Charlotte, North Carolina
    Carolinas Medical Center
Apr 19, 2022

Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)

Active, not recruiting
  • Acute Myeloid Leukemia
  • La Jolla, California
  • +69 more
Apr 5, 2022

Sickle Cell Disease Trial in Paris (Famotidine 400 mg/50 mL)

Recruiting
  • Sickle Cell Disease
  • Famotidine 400 mg/50 mL
  • Paris, France
    Necker - Enfants malades Hospital; Department of Pediatrics and
Oct 10, 2022

Pancreas Cancer Trial (mRNA expression)

Not yet recruiting
  • Pancreas Cancer
  • mRNA expression
  • (no location specified)
Aug 8, 2022

Cardiometabolic Health Trial in Kallithéa (Conventional sea bream, Enriched sea bream)

Active, not recruiting
  • Cardiometabolic Health
  • Conventional sea bream
  • Enriched sea bream
  • Kallithéa, Attica, Greece
    Department of Nutrition and Dietetics, School of Health Sciences
Jan 24, 2022

Community-acquired Pneumonia, Hospital-acquired Pneumonia Trial in Athens (Anakinra Prefilled Syringe, Placebo)

Recruiting
  • Community-acquired Pneumonia
  • Hospital-acquired Pneumonia
  • Anakinra Prefilled Syringe
  • Placebo
  • Athens, Greece
  • +1 more
Mar 14, 2023

Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Peripheral T Cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing/China, China
  • +1 more
Oct 9, 2023

COPD Trial in Worldwide (Open-Label, Placebo Comparator: Placebo-Control Arm 0.9% Sodium Chloride, ODSH)

Terminated
Has Results
  • Chronic Obstructive Pulmonary Disease
  • Orange, California
  • +37 more
Dec 1, 2021

Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

Recruiting
  • Cutaneous T-cell Lymphoma
  • Linperlisib in combined with Chidamide
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Sep 8, 2023

Relapsed/Refractory AML Trial in Tianjin, Hangzhou (Uproleselan, Placebo)

Recruiting
  • Relapsed/Refractory AML
  • Tianjin, Tianjin, China
  • +1 more
Nov 22, 2021

Cervical Cancer Trial in Amsterdam (Anti-PD-1 antibody balstilimab)

Not yet recruiting
  • Cervical Cancer
  • Anti-PD-1 antibody balstilimab
  • Amsterdam, Netherlands
    Amsterdam UMC
Oct 17, 2023

Relapsed/Refractory AML Trial in Tianjin, Hangzhou (Uproleselan)

Recruiting
  • Relapsed/Refractory AML
  • Tianjin, Tianjin, China
  • +1 more
Sep 14, 2021

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

HIV Trial in Las Vegas, Austin (VH4004280, Placebo)

Not yet recruiting
  • HIV Infections
  • Las Vegas, Nevada
  • +1 more
Aug 21, 2023

Differentiated Thyroid Cancer Trial in Pavia (Pembrolizumab)

Not yet recruiting
  • Differentiated Thyroid Cancer
  • Pavia, Lombardia, Italy
    Istituti Clinici Scientifici Maugeri
May 5, 2023

Blood Vessel Function in Postmenopausal Women With Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Rochester, Minnesota
    Mayo Clinic
Jan 17, 2023

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Chronic Kidney Disease Trial (Part A - Lorundrostat QD + Dapaglifozin QD, Part A - Lorundrostat QD, Part B - Lorundrostat QD

Not yet recruiting
  • Chronic Kidney Disease
  • Part A - Lorundrostat QD + Dapaglifozin QD
  • +2 more
  • (no location specified)
Nov 27, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

Not yet recruiting
  • Adenoid Cystic Carcinoma
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2023

Healthy Trial in Biberach (BI 1810631, Itraconazole)

Recruiting
  • Healthy
  • Biberach, Germany
    Humanpharmakologisches Zentrum Biberach
Apr 27, 2023

Vonoprazan, Helicobacter Pylori Infection, Proton Pump Inhibitor Trial in Hangzhou (Tegoprazan, Esomeprazole)

Active, not recruiting
  • Vonoprazan
  • +2 more
  • Hangzhou, Zhejiang, China
    Hangzhou first people's Hospital
Dec 2, 2022

Acute Myeloid Leukemia (AML) Trial in Birmingham, San Francisco, New York (ZN-d5 ZN-c3, ZN-c3)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Birmingham, Alabama
  • +2 more
Jan 3, 2023

Atypical Hemolytic Uremic Syndrome (aHUS) Trial in Worldwide (Ravulizumab)

Active, not recruiting
Has Results
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Ravulizumab
  • Aurora, Colorado
  • +19 more
Nov 16, 2022